Gates Foundation and Unitaid to offer generic HIV injection for $40/year from 2027

The Gates Foundation and Unitaid have announced that generic versions of a twice-yearly HIV prevention injection will be available starting in 2027. The cost of the injection is expected to be approximately $40 per year. This initiative will be implemented in over 100 countries, with Indian pharmaceutical firms producing the drug under new agreements.

This development aims to enhance access to HIV prevention methods globally, particularly in regions where the disease is prevalent. The collaboration between the Gates Foundation and Unitaid is part of ongoing efforts to combat the HIV epidemic and improve public health outcomes.

For further information on related topics, refer to recent developments in the political landscape.

Image for Gates Foundation and Unitaid to offer generic HIV injection for $40/year from 2027